Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Rule 2.9 Announcement

1 Jul 2025 13:25

RNS Number : 2528P
De La Rue PLC
01 July 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

1 July 2025

 

De La Rue plc ("De La Rue" or "Company")

 

Rule 2.9 Announcement

 

 

 

De La Rue announces that on 1 July 2025, it issued 4,864,009 ordinary shares of 44.8686 pence each in the capital of the Company ("Ordinary Shares") in satisfaction of the exercise of options under De La Rue Sharesave Scheme, De La Rue Sharesave Plan 2022, De La Rue Deferred Bonus Plan 2020, De La Rue Performance Share Plan, De La Rue Performance Share Plan 2020 and De La Rue Investor Returns Plan 2023. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), and further to the announcement made on 4 February 2025, as at the date of this announcement, De La Rue therefore has 201,296,031 Ordinary Shares in issue, each with voting rights, under the ISIN code GB00B3DGH821.

 

Jon Messent

Company Secretary

01256 605212

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78

 

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTFLFFFDFILIIE
Date   Source Headline
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company
27th Jun 20231:54 pmRNSHolding(s) in Company
26th Jun 20237:00 amRNSDirectorate Change
22nd Jun 20234:43 pmRNSHolding(s) in Company
21st Jun 20233:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSDirectorate Change
12th Jun 20237:00 amRNSDirectorate Change
1st Jun 202310:36 amRNSTotal Voting Rights
23rd May 20234:33 pmRNSHolding(s) in Company
18th May 20237:00 amRNSAppointment of Chairman
9th May 20237:00 amRNSNotice of Results
2nd May 20237:00 amRNSFurther re recruitment of Chairman
18th Apr 20232:52 pmRNSWithdrawal of General Meeting requisition
14th Apr 20234:19 pmRNSResignation of Chairman and accelerated search
12th Apr 20237:00 amRNSTrading update
6th Apr 20237:00 amRNSFurther re appointment of CFO
3rd Apr 202311:41 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSNotice of GM
30th Mar 202312:24 pmRNSHolding(s) in Company
24th Mar 202310:46 amRNSHolding(s) in Company
23rd Mar 202310:38 amRNSHolding(s) in Company
17th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20232:00 pmRNSHolding(s) in Company
22nd Feb 20231:03 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSDirectorate Change
20th Jan 20237:00 amRNSStatement re Kenya and India
6th Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 202312:14 pmRNSBlock listing Interim Review
2nd Dec 20224:42 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.